Alzheimers disease risk assessment

 
   Lead Investigator:    Michael Farnum
   Institution      :    Johnson and Johnson
   E-Mail           :    mfarnum@its.jnj.com
   Proposal ID      :    192



   Proposal Description:
   Our data mining group with JJ is interested in many aspects of Alzheimers        disease, including studying naturalistic progression, biomarkers, and             optimizing clinical endpoints and inclusion criteria.                                                                                                               We intend to test the hypothesis that APOE genotype in combination with           epidemiologic, cognitive, and behavioral factors is more predictive of future     risk for developing Alzheimers disease than APOE status alone.